Literature DB >> 11368898

Chromosomal location of murine disabled-2 gene and structural comparison with its human ortholog.

Z Sheng1, E R Smith, J He, J A Tuppen, W D Martin, F B Dong, X X Xu.   

Abstract

Disabled-2 (Dab2) is one of the two mammalian orthologs of the Drosophila Disabled. The three spliced forms, p96, p93, and p67 of murine Dab2 cDNAs were first isolated as phosphoproteins functioning in the macrophage CSF-1 signal transduction pathway. Subsequently, the involvement of Dab2 in ovarian cancer development has been investigated: Dab2 expression is lost or greatly diminished in breast and ovarian cancers, and gene deletions have been found. Regulation of Disabled-2 expression is also found to be important in development and physiological functions. Structural information of the murine Dab2 gene is essential for studies of transcription regulation and gene function in mouse models. In this study, the mouse Dab2 gene coding sequence was identified and sequenced from three lambda phage clones containing the gene. Two BAC clones of mouse genomic DNA were also used to identify the sequences of the non-coding first exon and promoter. The first exon is separated from the second exon by a large (15 kb) intron. The mouse gene is about 40 kb in size and consists of 15 exons, producing a 3.6 kb message. The translation initiation site resides in the middle of the second exon. The mouse Dab2 gene structure is very similar to that of its human ortholog in exon/intron sizes and promoter sequences. The chromosomal localization of mouse Dab2 was mapped by FISH to chromosome 15A2, a site of syntax with the human 5p12 where human Dab2 gene resides. The information on the mouse Dab2 gene structure and promoter will be invaluable in studies of the involvement of Dab2 gene in cancer, expression, physiological function, and development in mouse models.

Entities:  

Mesh:

Year:  2001        PMID: 11368898     DOI: 10.1016/s0378-1119(01)00401-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer.

Authors:  Yoshimitsu Akiyama; Neil Watkins; Hiromu Suzuki; Kam-Wing Jair; Manon van Engeland; Manel Esteller; Hidekazu Sakai; Chun-Yan Ren; Yasuhito Yuasa; James G Herman; Stephen B Baylin
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

2.  Hormonal induction and roles of Disabled-2 in lactation and involution.

Authors:  Wensi Tao; Robert Moore; Elizabeth R Smith; Xiang-Xi Xu
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

3.  Disabled-2: a positive regulator of the early differentiation of myoblasts.

Authors:  Na Shang; Juliana Tsz Yan Lee; Taida Huang; Chengdong Wang; Tin Lap Lee; Samuel C Mok; Hui Zhao; Wood Yee Chan
Journal:  Cell Tissue Res       Date:  2020-06-30       Impact factor: 5.249

4.  Dynamic expression of Dab2 in the mouse embryonic central nervous system.

Authors:  Kwok-Kuen Cheung; Samuel C Mok; Payam Rezaie; Wood Yee Chan
Journal:  BMC Dev Biol       Date:  2008-08-04       Impact factor: 1.978

Review 5.  Frequent loss expression of dab2 and promotor hypermethylation in human cancers: a meta-analysis and systematic review.

Authors:  Ziyin Zhang; Yihua Chen; Jianjian Tang; Xuemei Xie
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

6.  Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues.

Authors:  Robert Moore; Kathy Qi Cai; Wensi Tao; Elizabeth R Smith; Xiang-Xi Xu
Journal:  BMC Dev Biol       Date:  2013-10-29       Impact factor: 1.978

Review 7.  Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.

Authors:  Wensi Tao; Robert Moore; Elizabeth R Smith; Xiang-Xi Xu
Journal:  Front Cell Dev Biol       Date:  2016-11-25

Review 8.  Endocytic Adaptors in Cardiovascular Disease.

Authors:  Kui Cui; Yunzhou Dong; Beibei Wang; Douglas B Cowan; Siu-Lung Chan; John Shyy; Hong Chen
Journal:  Front Cell Dev Biol       Date:  2020-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.